

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 4.71357459 |
| 2 | actin-myosin filament sliding (GO:0033275) | 4.71357459 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.69394167 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.69394167 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 4.56869691 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.51862943 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.51862943 |
| 8 | regulation of sequestering of triglyceride (GO:0010889) | 4.43957893 |
| 9 | fatty acid transmembrane transport (GO:1902001) | 4.40379351 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.26721368 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21360644 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.11881829 |
| 13 | carnitine shuttle (GO:0006853) | 4.09507539 |
| 14 | fatty acid beta-oxidation (GO:0006635) | 4.08648859 |
| 15 | myofibril assembly (GO:0030239) | 4.01920771 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 4.01015897 |
| 17 | cardiac myofibril assembly (GO:0055003) | 3.99063660 |
| 18 | actin-mediated cell contraction (GO:0070252) | 3.97845502 |
| 19 | regulation of sarcomere organization (GO:0060297) | 3.97617575 |
| 20 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.96491687 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.91671136 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.87012094 |
| 23 | fatty acid oxidation (GO:0019395) | 3.79173619 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.78828276 |
| 25 | sarcomere organization (GO:0045214) | 3.78041176 |
| 26 | fatty acid catabolic process (GO:0009062) | 3.76915998 |
| 27 | complement activation, alternative pathway (GO:0006957) | 3.75635846 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 3.73739516 |
| 29 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.73731164 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 3.73633899 |
| 31 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.73236159 |
| 32 | acylglycerol homeostasis (GO:0055090) | 3.72951478 |
| 33 | triglyceride homeostasis (GO:0070328) | 3.72951478 |
| 34 | bile acid biosynthetic process (GO:0006699) | 3.72727252 |
| 35 | lipid oxidation (GO:0034440) | 3.72520562 |
| 36 | negative regulation of protein localization to cell surface (GO:2000009) | 3.72308845 |
| 37 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.68532617 |
| 38 | low-density lipoprotein particle clearance (GO:0034383) | 3.68346709 |
| 39 | NADH metabolic process (GO:0006734) | 3.67990289 |
| 40 | fatty acid homeostasis (GO:0055089) | 3.67052142 |
| 41 | endothelium development (GO:0003158) | 3.65999982 |
| 42 | lysine metabolic process (GO:0006553) | 3.60492414 |
| 43 | lysine catabolic process (GO:0006554) | 3.60492414 |
| 44 | regulation of relaxation of muscle (GO:1901077) | 3.59458703 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.57198965 |
| 46 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.54833158 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 3.53990035 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.53653418 |
| 49 | acetyl-CoA metabolic process (GO:0006084) | 3.53508218 |
| 50 | regulation of lipoprotein metabolic process (GO:0050746) | 3.52801915 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.52306488 |
| 52 | positive regulation of lipid catabolic process (GO:0050996) | 3.51256541 |
| 53 | monocarboxylic acid catabolic process (GO:0072329) | 3.50526183 |
| 54 | kynurenine metabolic process (GO:0070189) | 3.49708305 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 3.49184876 |
| 56 | biotin metabolic process (GO:0006768) | 3.46725896 |
| 57 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.46361048 |
| 58 | triglyceride catabolic process (GO:0019433) | 3.44287211 |
| 59 | glyoxylate metabolic process (GO:0046487) | 3.42416837 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 3.42413018 |
| 61 | protein carboxylation (GO:0018214) | 3.38564634 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38564634 |
| 63 | negative regulation of lipase activity (GO:0060192) | 3.38049533 |
| 64 | regulation of complement activation (GO:0030449) | 3.37991606 |
| 65 | acylglycerol catabolic process (GO:0046464) | 3.37487810 |
| 66 | neutral lipid catabolic process (GO:0046461) | 3.37487810 |
| 67 | tyrosine metabolic process (GO:0006570) | 3.37087233 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.34836975 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.34429074 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.34015213 |
| 71 | ethanol metabolic process (GO:0006067) | 3.32796535 |
| 72 | urea metabolic process (GO:0019627) | 3.32369813 |
| 73 | urea cycle (GO:0000050) | 3.32369813 |
| 74 | regulation of fibrinolysis (GO:0051917) | 3.31642462 |
| 75 | cellular response to epinephrine stimulus (GO:0071872) | 3.29566127 |
| 76 | regulation of fatty acid oxidation (GO:0046320) | 3.28598316 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.26028494 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 3.24346979 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 3.24346979 |
| 80 | tryptophan catabolic process (GO:0006569) | 3.24346979 |
| 81 | carnitine metabolic process (GO:0009437) | 3.24128826 |
| 82 | plasma membrane repair (GO:0001778) | 3.23989444 |
| 83 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.23185268 |
| 84 | bile acid metabolic process (GO:0008206) | 3.19463035 |
| 85 | response to epinephrine (GO:0071871) | 3.19322546 |
| 86 | valine metabolic process (GO:0006573) | 3.18113923 |
| 87 | carnitine transmembrane transport (GO:1902603) | 3.17840855 |
| 88 | creatine metabolic process (GO:0006600) | 3.17603128 |
| 89 | tryptophan metabolic process (GO:0006568) | 3.17467649 |
| 90 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.13381532 |
| 91 | lipid particle organization (GO:0034389) | 3.12452856 |
| 92 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.12378947 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.10353051 |
| 94 | cardiac muscle contraction (GO:0060048) | 3.09335237 |
| 95 | protein-lipid complex remodeling (GO:0034368) | 3.09194083 |
| 96 | macromolecular complex remodeling (GO:0034367) | 3.09194083 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.09194083 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 3.07663344 |
| 99 | transcytosis (GO:0045056) | 3.06632536 |
| 100 | glycerolipid catabolic process (GO:0046503) | 3.03967450 |
| 101 | alkaloid metabolic process (GO:0009820) | 3.03833460 |
| 102 | striated muscle contraction (GO:0006941) | 3.03649199 |
| 103 | coenzyme catabolic process (GO:0009109) | 3.01962453 |
| 104 | branched-chain amino acid catabolic process (GO:0009083) | 3.01538312 |
| 105 | phospholipid homeostasis (GO:0055091) | 3.00652500 |
| 106 | skeletal muscle contraction (GO:0003009) | 3.00587150 |
| 107 | phospholipid efflux (GO:0033700) | 2.99941987 |
| 108 | lymphangiogenesis (GO:0001946) | 2.99923300 |
| 109 | cysteine metabolic process (GO:0006534) | 2.98076020 |
| 110 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97888810 |
| 111 | negative regulation of heart growth (GO:0061117) | 2.97609936 |
| 112 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.97609936 |
| 113 | actin filament-based movement (GO:0030048) | 2.97302063 |
| 114 | carnitine transport (GO:0015879) | 2.96924895 |
| 115 | amino-acid betaine transport (GO:0015838) | 2.96924895 |
| 116 | regulation of actin filament-based movement (GO:1903115) | 2.96851799 |
| 117 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.96846372 |
| 118 | actomyosin structure organization (GO:0031032) | 2.96758159 |
| 119 | primary alcohol catabolic process (GO:0034310) | 2.96399934 |
| 120 | aromatic amino acid family metabolic process (GO:0009072) | 2.94788954 |
| 121 | alpha-amino acid catabolic process (GO:1901606) | 2.93497072 |
| 122 | ethanol oxidation (GO:0006069) | 2.93271183 |
| 123 | positive regulation of lipid storage (GO:0010884) | 2.92872721 |
| 124 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.92023836 |
| 125 | cGMP-mediated signaling (GO:0019934) | 2.91488814 |
| 126 | organic acid catabolic process (GO:0016054) | 2.90590714 |
| 127 | carboxylic acid catabolic process (GO:0046395) | 2.90590714 |
| 128 | skeletal muscle adaptation (GO:0043501) | 2.90413827 |
| 129 | homocysteine metabolic process (GO:0050667) | 2.87381580 |
| 130 | glomerular filtration (GO:0003094) | 2.86752894 |
| 131 | brown fat cell differentiation (GO:0050873) | 2.86676724 |
| 132 | regulation of cholesterol esterification (GO:0010872) | 2.85495681 |
| 133 | striated muscle atrophy (GO:0014891) | 2.84949020 |
| 134 | ketone body metabolic process (GO:1902224) | 2.84743164 |
| 135 | desmosome organization (GO:0002934) | 2.84405542 |
| 136 | polyol transport (GO:0015791) | 2.84397291 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.84366408 |
| 138 | fibrinolysis (GO:0042730) | 2.82916035 |
| 139 | regulation of triglyceride metabolic process (GO:0090207) | 2.81736864 |
| 140 | regulation of cholesterol metabolic process (GO:0090181) | 2.81429283 |
| 141 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.80957326 |
| 142 | diacylglycerol metabolic process (GO:0046339) | 2.80063271 |
| 143 | branched-chain amino acid metabolic process (GO:0009081) | 2.79237911 |
| 144 | serine family amino acid catabolic process (GO:0009071) | 2.78802795 |
| 145 | response to muscle activity (GO:0014850) | 2.78652103 |
| 146 | aspartate family amino acid catabolic process (GO:0009068) | 2.76453048 |
| 147 | cellular amino acid catabolic process (GO:0009063) | 2.75809001 |
| 148 | epoxygenase P450 pathway (GO:0019373) | 2.74718269 |
| 149 | response to inactivity (GO:0014854) | 2.74238488 |
| 150 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.73862373 |
| 151 | acyl-CoA metabolic process (GO:0006637) | 2.73759301 |
| 152 | thioester metabolic process (GO:0035383) | 2.73759301 |
| 153 | ovulation from ovarian follicle (GO:0001542) | 2.72517578 |
| 154 | thioester biosynthetic process (GO:0035384) | 2.72092230 |
| 155 | acyl-CoA biosynthetic process (GO:0071616) | 2.72092230 |
| 156 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.69106092 |
| 157 | muscle contraction (GO:0006936) | 2.69015134 |
| 158 | primary alcohol metabolic process (GO:0034308) | 2.68110810 |
| 159 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.66334728 |
| 160 | detection of calcium ion (GO:0005513) | 2.65869378 |
| 161 | myotube cell development (GO:0014904) | 2.64114855 |
| 162 | cardiac muscle hypertrophy (GO:0003300) | 2.61944928 |
| 163 | positive regulation of glomerulus development (GO:0090193) | 2.61825819 |
| 164 | regulation of cholesterol storage (GO:0010885) | 2.58858721 |
| 165 | regulation of striated muscle contraction (GO:0006942) | 2.56949602 |
| 166 | renal filtration (GO:0097205) | 2.56688538 |
| 167 | positive regulation of vascular permeability (GO:0043117) | 2.56360118 |
| 168 | heart contraction (GO:0060047) | 2.55678409 |
| 169 | heart process (GO:0003015) | 2.55678409 |
| 170 | striated muscle hypertrophy (GO:0014897) | 2.55445214 |
| 171 | glycerol metabolic process (GO:0006071) | 2.55293845 |
| 172 | blood vessel maturation (GO:0001955) | 2.55244942 |
| 173 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.55032774 |
| 174 | regulation of membrane repolarization (GO:0060306) | 2.50317039 |
| 175 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.48906694 |
| 176 | skeletal muscle fiber development (GO:0048741) | 2.48608408 |
| 177 | muscle system process (GO:0003012) | 2.48042849 |
| 178 | regulation of the force of heart contraction (GO:0002026) | 2.47936137 |
| 179 | heart trabecula formation (GO:0060347) | 2.46287549 |
| 180 | glycogen catabolic process (GO:0005980) | 2.45550546 |
| 181 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.45300240 |
| 182 | endocrine hormone secretion (GO:0060986) | 2.44496425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.40692114 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.19239003 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39926422 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.75486477 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.71374538 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.24306694 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91229273 |
| 8 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90957757 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.80245205 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63168414 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.24818407 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03559413 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94995364 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90647630 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86359370 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82322294 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81877800 |
| 18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.73472697 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73227268 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71726325 |
| 21 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70302487 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70256750 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60012630 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58032158 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55383506 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53066831 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49767854 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47896505 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45988080 |
| 30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38018257 |
| 31 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31267698 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30960464 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30078350 |
| 34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.29652372 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29336319 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28142025 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27798714 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26453798 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26080364 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.25892222 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25295234 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25295234 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24448874 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22501521 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22420049 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22420049 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20942256 |
| 48 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19866849 |
| 49 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18838574 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18446071 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18331088 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17963704 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17638293 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17387130 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16427790 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15391145 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15031993 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14736744 |
| 59 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14436947 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11378161 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11174326 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11089038 |
| 63 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11030165 |
| 64 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11030165 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09677978 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08553669 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08413855 |
| 68 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07176000 |
| 69 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07166875 |
| 70 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.07079067 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06223850 |
| 72 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05948234 |
| 73 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05857345 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05524132 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05403319 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02497036 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01850822 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99261281 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98938150 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98920173 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97129437 |
| 82 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96413428 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95777401 |
| 84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94729316 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94413218 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94176067 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93568666 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93071692 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92061957 |
| 90 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91923541 |
| 91 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91123858 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90850886 |
| 93 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90836528 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90428634 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89960741 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89763399 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88956861 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87447251 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86941141 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85948169 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85761991 |
| 102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85094406 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83948600 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83632034 |
| 105 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83454222 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83362309 |
| 107 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83259248 |
| 108 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82393807 |
| 109 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80236198 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79921832 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79891660 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79851515 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79719808 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77461968 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77427975 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76358236 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75399064 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.74157203 |
| 119 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.73178334 |
| 120 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.73171443 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.72277693 |
| 122 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.71264628 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71240203 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70394146 |
| 125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70220991 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70115785 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69857163 |
| 128 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.69642076 |
| 129 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69389842 |
| 130 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.68877935 |
| 131 | RXR_22108803_ChIP-Seq_LS180_Human | 0.67838123 |
| 132 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.66797806 |
| 133 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66508333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.96827348 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 4.36852860 |
| 3 | MP0005360_urolithiasis | 4.29030633 |
| 4 | MP0005365_abnormal_bile_salt | 4.02579921 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.39348308 |
| 6 | MP0005670_abnormal_white_adipose | 3.26562721 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.18782044 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11477220 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.08418085 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.01154860 |
| 11 | MP0004130_abnormal_muscle_cell | 2.76999168 |
| 12 | MP0003252_abnormal_bile_duct | 2.39619553 |
| 13 | MP0002822_catalepsy | 2.22972135 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.22970493 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.00232156 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 1.91878828 |
| 17 | MP0000751_myopathy | 1.91279393 |
| 18 | MP0005083_abnormal_biliary_tract | 1.90620406 |
| 19 | MP0002106_abnormal_muscle_physiology | 1.87274820 |
| 20 | MP0004215_abnormal_myocardial_fiber | 1.78915901 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.78355546 |
| 22 | MP0005369_muscle_phenotype | 1.76809455 |
| 23 | MP0005332_abnormal_amino_acid | 1.73935547 |
| 24 | MP0005275_abnormal_skin_tensile | 1.71911701 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.69158536 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 1.66179748 |
| 27 | MP0004272_abnormal_basement_membrane | 1.59072844 |
| 28 | MP0003646_muscle_fatigue | 1.59012137 |
| 29 | MP0002254_reproductive_system_inflammat | 1.58419907 |
| 30 | MP0002796_impaired_skin_barrier | 1.58246741 |
| 31 | MP0005330_cardiomyopathy | 1.55979292 |
| 32 | MP0000747_muscle_weakness | 1.55384832 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.53316619 |
| 34 | MP0002971_abnormal_brown_adipose | 1.52439743 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.52377489 |
| 36 | MP0000609_abnormal_liver_physiology | 1.51466728 |
| 37 | MP0006138_congestive_heart_failure | 1.49223370 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.47015331 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.46713860 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.46232328 |
| 41 | MP0001879_abnormal_lymphatic_vessel | 1.44107209 |
| 42 | MP0003195_calcinosis | 1.41617235 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.41360837 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.40471871 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.38016753 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.37618301 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.35865620 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.35710971 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.34017257 |
| 50 | MP0009840_abnormal_foam_cell | 1.32902167 |
| 51 | MP0005535_abnormal_body_temperature | 1.32365171 |
| 52 | MP0003724_increased_susceptibility_to | 1.31467386 |
| 53 | MP0000749_muscle_degeneration | 1.31137645 |
| 54 | MP0003959_abnormal_lean_body | 1.29738487 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.28167473 |
| 56 | MP0003279_aneurysm | 1.28066590 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.25235991 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.24812776 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.21941382 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17981742 |
| 61 | MP0009697_abnormal_copulation | 1.17895777 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.17459499 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.17459499 |
| 64 | MP0005334_abnormal_fat_pad | 1.14862604 |
| 65 | MP0004087_abnormal_muscle_fiber | 1.10041665 |
| 66 | MP0000733_abnormal_muscle_development | 1.07292957 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.05111024 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.05014280 |
| 69 | MP0003828_pulmonary_edema | 1.04987785 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.04847782 |
| 71 | MP0004484_altered_response_of | 1.03793435 |
| 72 | MP0002332_abnormal_exercise_endurance | 1.03740671 |
| 73 | MP0002060_abnormal_skin_morphology | 1.03192177 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.02000313 |
| 75 | MP0003186_abnormal_redox_activity | 0.97974506 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.97327274 |
| 77 | MP0009115_abnormal_fat_cell | 0.96446006 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.96397783 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.94041974 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.93469318 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.93316277 |
| 82 | MP0003868_abnormal_feces_composition | 0.92577231 |
| 83 | MP0004233_abnormal_muscle_weight | 0.90809436 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.89538323 |
| 85 | MP0004085_abnormal_heartbeat | 0.88651202 |
| 86 | MP0010630_abnormal_cardiac_muscle | 0.85677556 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.85363072 |
| 88 | MP0001764_abnormal_homeostasis | 0.84574378 |
| 89 | MP0002933_joint_inflammation | 0.84197800 |
| 90 | MP0002128_abnormal_blood_circulation | 0.83485948 |
| 91 | MP0003011_delayed_dark_adaptation | 0.82969679 |
| 92 | MP0000249_abnormal_blood_vessel | 0.81539516 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.80484690 |
| 94 | MP0000579_abnormal_nail_morphology | 0.80160249 |
| 95 | MP0005266_abnormal_metabolism | 0.79876327 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.79749235 |
| 97 | MP0001756_abnormal_urination | 0.79543930 |
| 98 | MP0005165_increased_susceptibility_to | 0.79196609 |
| 99 | MP0004147_increased_porphyrin_level | 0.78582946 |
| 100 | MP0000266_abnormal_heart_morphology | 0.75343971 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.74963131 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.74526075 |
| 103 | MP0000538_abnormal_urinary_bladder | 0.72471150 |
| 104 | MP0005452_abnormal_adipose_tissue | 0.72413328 |
| 105 | MP0005647_abnormal_sex_gland | 0.72036172 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.70982501 |
| 107 | MP0002269_muscular_atrophy | 0.70477256 |
| 108 | MP0004858_abnormal_nervous_system | 0.70092151 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.69440105 |
| 110 | MP0008874_decreased_physiological_sensi | 0.69411222 |
| 111 | MP0001661_extended_life_span | 0.68871249 |
| 112 | MP0002970_abnormal_white_adipose | 0.68250621 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.68032861 |
| 114 | MP0005448_abnormal_energy_balance | 0.67950111 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.66712573 |
| 116 | MP0002108_abnormal_muscle_morphology | 0.66493141 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.65940664 |
| 118 | MP0005409_darkened_coat_color | 0.65050439 |
| 119 | MP0000343_altered_response_to | 0.64941225 |
| 120 | MP0004510_myositis | 0.64772921 |
| 121 | MP0003948_abnormal_gas_homeostasis | 0.63735266 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.59940025 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.59341927 |
| 124 | MP0005187_abnormal_penis_morphology | 0.57435048 |
| 125 | MP0005164_abnormal_response_to | 0.56553844 |
| 126 | MP0003690_abnormal_glial_cell | 0.54960333 |
| 127 | MP0001958_emphysema | 0.53015554 |
| 128 | MP0003045_fibrosis | 0.52085656 |
| 129 | MP0001614_abnormal_blood_vessel | 0.51758996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.44793099 |
| 2 | Nemaline bodies (HP:0003798) | 5.41724089 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.35003920 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.04861831 |
| 5 | Asymmetric septal hypertrophy (HP:0001670) | 4.88665518 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.70823374 |
| 7 | Xanthomatosis (HP:0000991) | 4.49320879 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35520310 |
| 9 | Hypoglycemic coma (HP:0001325) | 4.31059586 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.22051958 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.17684285 |
| 12 | Bundle branch block (HP:0011710) | 4.03279060 |
| 13 | Neck muscle weakness (HP:0000467) | 3.94339429 |
| 14 | Complement deficiency (HP:0004431) | 3.89983788 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 3.86533345 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.82084268 |
| 17 | Hyperammonemia (HP:0001987) | 3.81589012 |
| 18 | Hyperglycinuria (HP:0003108) | 3.81336584 |
| 19 | Ketosis (HP:0001946) | 3.75387204 |
| 20 | Subaortic stenosis (HP:0001682) | 3.73501919 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.73501919 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70456406 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.70402911 |
| 24 | Distal arthrogryposis (HP:0005684) | 3.67976298 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 3.61467247 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61048234 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.54643631 |
| 28 | Epidermoid cyst (HP:0200040) | 3.41358995 |
| 29 | Sudden death (HP:0001699) | 3.39447286 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.36920528 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36920528 |
| 32 | Ketoacidosis (HP:0001993) | 3.36168686 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.33747526 |
| 34 | Myoglobinuria (HP:0002913) | 3.30829424 |
| 35 | Hypolipoproteinemia (HP:0010981) | 3.29992032 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27461739 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 3.25792052 |
| 38 | Round ear (HP:0100830) | 3.24348935 |
| 39 | Protrusio acetabuli (HP:0003179) | 3.15657672 |
| 40 | Hyperglycinemia (HP:0002154) | 3.13411072 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 3.11190431 |
| 42 | Exercise-induced myalgia (HP:0003738) | 3.07657216 |
| 43 | Oligomenorrhea (HP:0000876) | 3.05267606 |
| 44 | Heart block (HP:0012722) | 3.04452914 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02627677 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.00581846 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 3.00581846 |
| 48 | Gowers sign (HP:0003391) | 2.99862888 |
| 49 | Acanthosis nigricans (HP:0000956) | 2.96974221 |
| 50 | Rimmed vacuoles (HP:0003805) | 2.94110204 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.93335051 |
| 52 | Abnormal atrioventricular conduction (HP:0005150) | 2.91775616 |
| 53 | Dilated cardiomyopathy (HP:0001644) | 2.84153404 |
| 54 | Aortic aneurysm (HP:0004942) | 2.81319115 |
| 55 | Cerebral edema (HP:0002181) | 2.78875720 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.74069945 |
| 57 | Increased connective tissue (HP:0009025) | 2.73624217 |
| 58 | Frequent falls (HP:0002359) | 2.72832576 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.70366021 |
| 60 | Abnormality of complement system (HP:0005339) | 2.67407813 |
| 61 | Ulnar deviation of the wrist (HP:0003049) | 2.64249010 |
| 62 | Arterial tortuosity (HP:0005116) | 2.60708938 |
| 63 | Spinal rigidity (HP:0003306) | 2.60240520 |
| 64 | Vascular tortuosity (HP:0004948) | 2.60095436 |
| 65 | Joint hemorrhage (HP:0005261) | 2.59298330 |
| 66 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59071885 |
| 67 | Rhabdomyolysis (HP:0003201) | 2.58821560 |
| 68 | Hypothermia (HP:0002045) | 2.58310239 |
| 69 | Areflexia of lower limbs (HP:0002522) | 2.57110160 |
| 70 | Palpitations (HP:0001962) | 2.55995535 |
| 71 | EMG: neuropathic changes (HP:0003445) | 2.51844250 |
| 72 | Myotonia (HP:0002486) | 2.46615685 |
| 73 | Hypertriglyceridemia (HP:0002155) | 2.45817762 |
| 74 | Metabolic acidosis (HP:0001942) | 2.45674128 |
| 75 | Muscle fiber splitting (HP:0003555) | 2.44033294 |
| 76 | Ventricular arrhythmia (HP:0004308) | 2.43767029 |
| 77 | Skin nodule (HP:0200036) | 2.40372679 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.40166650 |
| 79 | Lethargy (HP:0001254) | 2.39794658 |
| 80 | Muscle stiffness (HP:0003552) | 2.39491147 |
| 81 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.36709837 |
| 82 | Amyloidosis (HP:0011034) | 2.36058549 |
| 83 | Scapular winging (HP:0003691) | 2.33724853 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.33301975 |
| 85 | Difficulty running (HP:0009046) | 2.32852360 |
| 86 | Lymphangioma (HP:0100764) | 2.32200339 |
| 87 | Neonatal onset (HP:0003623) | 2.31119246 |
| 88 | Calf muscle hypertrophy (HP:0008981) | 2.29502334 |
| 89 | Prolonged QT interval (HP:0001657) | 2.29064046 |
| 90 | Hepatic necrosis (HP:0002605) | 2.28736850 |
| 91 | Hip contracture (HP:0003273) | 2.27529611 |
| 92 | Delayed CNS myelination (HP:0002188) | 2.27438734 |
| 93 | Malignant hyperthermia (HP:0002047) | 2.26763258 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26167272 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.24500077 |
| 96 | Increased muscle lipid content (HP:0009058) | 2.21265494 |
| 97 | Myocardial infarction (HP:0001658) | 2.20795511 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 2.20285428 |
| 99 | Hyperglycemia (HP:0003074) | 2.18493289 |
| 100 | Distal lower limb muscle weakness (HP:0009053) | 2.17902155 |
| 101 | Syncope (HP:0001279) | 2.17414322 |
| 102 | Pigmentary retinal degeneration (HP:0001146) | 2.16724702 |
| 103 | Fat malabsorption (HP:0002630) | 2.15847404 |
| 104 | Esophageal varix (HP:0002040) | 2.14933955 |
| 105 | Lipoatrophy (HP:0100578) | 2.14869900 |
| 106 | Hypoglycemic seizures (HP:0002173) | 2.13901442 |
| 107 | Abnormality of serum amino acid levels (HP:0003112) | 2.13481856 |
| 108 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13194588 |
| 109 | Abnormality of the intrinsic pathway (HP:0010989) | 2.12899054 |
| 110 | Abnormality of methionine metabolism (HP:0010901) | 2.12645508 |
| 111 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.11787964 |
| 112 | Atrial fibrillation (HP:0005110) | 2.11172949 |
| 113 | Absent phalangeal crease (HP:0006109) | 2.10001041 |
| 114 | Cerebral hemorrhage (HP:0001342) | 2.09473248 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07670965 |
| 116 | Acute encephalopathy (HP:0006846) | 2.06485365 |
| 117 | Vomiting (HP:0002013) | 2.05934121 |
| 118 | Abnormality of purine metabolism (HP:0004352) | 2.01818866 |
| 119 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01787524 |
| 120 | Cholelithiasis (HP:0001081) | 2.01457710 |
| 121 | Hyperkalemia (HP:0002153) | 2.01080824 |
| 122 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00945595 |
| 123 | Myopathic facies (HP:0002058) | 2.00095695 |
| 124 | Limited hip movement (HP:0008800) | 1.98638550 |
| 125 | Atrioventricular block (HP:0001678) | 1.98072878 |
| 126 | Primary atrial arrhythmia (HP:0001692) | 1.97583073 |
| 127 | Abnormal hemoglobin (HP:0011902) | 1.97508824 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.96510517 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.96510517 |
| 130 | Polycythemia (HP:0001901) | 1.96290866 |
| 131 | Abnormal gallbladder morphology (HP:0012437) | 1.94916975 |
| 132 | Popliteal pterygium (HP:0009756) | 1.94578236 |
| 133 | Vascular calcification (HP:0004934) | 1.93607711 |
| 134 | Conjunctival hamartoma (HP:0100780) | 1.92812186 |
| 135 | Generalized muscle weakness (HP:0003324) | 1.92014849 |
| 136 | Abnormality of the calf musculature (HP:0001430) | 1.87649892 |
| 137 | Bulbar palsy (HP:0001283) | 1.87353994 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.86820872 |
| 139 | Abnormality of the foot musculature (HP:0001436) | 1.86749418 |
| 140 | Nausea (HP:0002018) | 1.86493423 |
| 141 | Supraventricular arrhythmia (HP:0005115) | 1.85965894 |
| 142 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85744827 |
| 143 | Cardiovascular calcification (HP:0011915) | 1.85681160 |
| 144 | Steppage gait (HP:0003376) | 1.84742220 |
| 145 | Supraventricular tachycardia (HP:0004755) | 1.83747364 |
| 146 | Renal cortical cysts (HP:0000803) | 1.80834634 |
| 147 | Fatigable weakness (HP:0003473) | 1.79821504 |
| 148 | Abnormality of the neuromuscular junction (HP:0003398) | 1.79821504 |
| 149 | Hypotrichosis (HP:0001006) | 1.79288258 |
| 150 | Left ventricular hypertrophy (HP:0001712) | 1.76997708 |
| 151 | Foot dorsiflexor weakness (HP:0009027) | 1.76483151 |
| 152 | Calcaneovalgus deformity (HP:0001848) | 1.75389205 |
| 153 | Fibular aplasia (HP:0002990) | 1.75140214 |
| 154 | Muscular dystrophy (HP:0003560) | 1.74738533 |
| 155 | Abnormal finger flexion creases (HP:0006143) | 1.72331017 |
| 156 | Back pain (HP:0003418) | 1.71881091 |
| 157 | Aortic dissection (HP:0002647) | 1.67018544 |
| 158 | Striae distensae (HP:0001065) | 1.64138414 |
| 159 | Proximal amyotrophy (HP:0007126) | 1.62414108 |
| 160 | Polar cataract (HP:0010696) | 1.62158311 |
| 161 | Increased serum pyruvate (HP:0003542) | 1.61766882 |
| 162 | Abnormal EKG (HP:0003115) | 1.60966937 |
| 163 | Subcapsular cataract (HP:0000523) | 1.59709425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.98229857 |
| 2 | BCKDK | 3.60286678 |
| 3 | SIK1 | 2.77629655 |
| 4 | INSRR | 2.58866852 |
| 5 | LMTK2 | 2.55034801 |
| 6 | TRIB3 | 2.11990141 |
| 7 | MST1R | 2.05355349 |
| 8 | FGFR4 | 2.04402665 |
| 9 | PDK3 | 2.02101081 |
| 10 | PDK4 | 2.02101081 |
| 11 | MYLK | 1.99557480 |
| 12 | MARK1 | 1.96178840 |
| 13 | OBSCN | 1.95138010 |
| 14 | KDR | 1.94308007 |
| 15 | FER | 1.87212949 |
| 16 | ERN1 | 1.87068324 |
| 17 | PHKG2 | 1.80716232 |
| 18 | PHKG1 | 1.80716232 |
| 19 | EPHB2 | 1.78941555 |
| 20 | PDK2 | 1.72067518 |
| 21 | GRK5 | 1.69904855 |
| 22 | DAPK2 | 1.64695079 |
| 23 | TTN | 1.57428755 |
| 24 | RIPK1 | 1.56710398 |
| 25 | MAPKAPK3 | 1.56530610 |
| 26 | GRK7 | 1.51019975 |
| 27 | NTRK1 | 1.47531938 |
| 28 | CAMK1D | 1.46511787 |
| 29 | TGFBR1 | 1.43976383 |
| 30 | MAPKAPK5 | 1.40955189 |
| 31 | MAP2K4 | 1.39751053 |
| 32 | PTK2B | 1.39055934 |
| 33 | TGFBR2 | 1.37971916 |
| 34 | MAP2K1 | 1.37672094 |
| 35 | LATS1 | 1.37099043 |
| 36 | FGFR2 | 1.32839841 |
| 37 | PIK3CA | 1.29948347 |
| 38 | PRKAA2 | 1.27099263 |
| 39 | EPHA3 | 1.26901987 |
| 40 | BMPR1B | 1.25192178 |
| 41 | EEF2K | 1.19334380 |
| 42 | DDR2 | 1.18210498 |
| 43 | MAP3K3 | 1.14325276 |
| 44 | MAPK12 | 1.11132618 |
| 45 | LATS2 | 1.07809373 |
| 46 | MAP3K2 | 1.06070270 |
| 47 | MAPK13 | 1.04989203 |
| 48 | CAMK1G | 1.02237126 |
| 49 | FRK | 1.01640139 |
| 50 | MAPK15 | 1.00405394 |
| 51 | PINK1 | 0.96743098 |
| 52 | EPHA4 | 0.96726643 |
| 53 | CDK8 | 0.93158964 |
| 54 | MOS | 0.91652442 |
| 55 | NEK9 | 0.91465642 |
| 56 | CCNB1 | 0.91243252 |
| 57 | PKN1 | 0.90951030 |
| 58 | GRK1 | 0.87339407 |
| 59 | NTRK3 | 0.86667797 |
| 60 | FGFR3 | 0.86229927 |
| 61 | STK38L | 0.80205918 |
| 62 | MAP3K7 | 0.79377808 |
| 63 | PRKD1 | 0.78341729 |
| 64 | RET | 0.78049635 |
| 65 | PKN2 | 0.73223465 |
| 66 | PRKCE | 0.72837521 |
| 67 | MAPK11 | 0.71659512 |
| 68 | PRKG1 | 0.71203927 |
| 69 | PIK3CG | 0.70255282 |
| 70 | PRKAA1 | 0.67733998 |
| 71 | AKT3 | 0.66733384 |
| 72 | PAK3 | 0.66032143 |
| 73 | MET | 0.65624286 |
| 74 | PRKACG | 0.64992317 |
| 75 | NLK | 0.63341882 |
| 76 | KSR2 | 0.61701152 |
| 77 | PDPK1 | 0.61594332 |
| 78 | SGK2 | 0.60653943 |
| 79 | JAK1 | 0.60212236 |
| 80 | PTK6 | 0.59297430 |
| 81 | ADRBK1 | 0.59111168 |
| 82 | IGF1R | 0.58554271 |
| 83 | STK24 | 0.57715339 |
| 84 | BCR | 0.57583777 |
| 85 | MAP3K1 | 0.57108791 |
| 86 | JAK2 | 0.57089783 |
| 87 | CDC42BPA | 0.56273249 |
| 88 | MAPK4 | 0.55755978 |
| 89 | PDGFRA | 0.55324358 |
| 90 | ERBB4 | 0.54611895 |
| 91 | MAP2K3 | 0.54246943 |
| 92 | PRKACB | 0.53633039 |
| 93 | MAP3K12 | 0.53201710 |
| 94 | CDK9 | 0.52153771 |
| 95 | MUSK | 0.51157813 |
| 96 | ABL2 | 0.50704409 |
| 97 | CAMK2A | 0.50630075 |
| 98 | TRPM7 | 0.49895883 |
| 99 | CAMK2G | 0.49640649 |
| 100 | CAMK2D | 0.49115267 |
| 101 | DMPK | 0.47612865 |
| 102 | LIMK1 | 0.47518184 |
| 103 | SGK3 | 0.46887555 |
| 104 | SGK223 | 0.46705349 |
| 105 | SGK494 | 0.46705349 |
| 106 | PRKCH | 0.46419683 |
| 107 | ERBB3 | 0.45458549 |
| 108 | AKT2 | 0.44406415 |
| 109 | GSK3A | 0.44307772 |
| 110 | PRKACA | 0.42724175 |
| 111 | RPS6KA3 | 0.42603479 |
| 112 | PTK2 | 0.42538273 |
| 113 | CAMK4 | 0.42346097 |
| 114 | CAMKK2 | 0.42066156 |
| 115 | ROCK1 | 0.42034592 |
| 116 | ROCK2 | 0.41844753 |
| 117 | PAK2 | 0.40949997 |
| 118 | CAMK2B | 0.40515883 |
| 119 | PRKG2 | 0.39156707 |
| 120 | CASK | 0.39110941 |
| 121 | PRKCZ | 0.37956787 |
| 122 | MINK1 | 0.37623272 |
| 123 | MAPK7 | 0.37111007 |
| 124 | EPHB1 | 0.36589084 |
| 125 | MAP3K4 | 0.36293927 |
| 126 | CAMK1 | 0.36141524 |
| 127 | MARK2 | 0.35406973 |
| 128 | MAP3K6 | 0.33149107 |
| 129 | IRAK1 | 0.31077486 |
| 130 | MTOR | 0.28367822 |
| 131 | STK11 | 0.27659281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32856771 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.06644431 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.99882818 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.85562688 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77399925 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.63666342 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54337909 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53726013 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44674984 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39752697 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32537248 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.29024612 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25082301 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13846508 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06482536 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00038830 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95120198 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.91318387 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.90742613 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.85002396 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83137218 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79729509 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71904766 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63508761 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62747255 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55756123 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.46083783 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44506436 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44125340 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43176483 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41276093 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38345880 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37633632 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32828708 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31424431 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25685875 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22684717 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20722639 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19613967 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18125367 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.16501688 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12286909 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10895098 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08905200 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04919454 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 1.04522704 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01887159 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.00868597 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90097954 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88163283 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87612198 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87304248 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81494946 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74171572 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71513675 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.71149236 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70023609 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69396220 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68931499 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67339227 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65762234 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65703819 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 0.64633408 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63504190 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62144238 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61216242 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59729371 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.55979552 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55500050 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.54316434 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51645870 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47898430 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47577455 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46163832 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45303095 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.44860302 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41991077 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41967836 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41661045 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41543336 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39784330 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36980674 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36054848 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33638360 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.32082834 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32023981 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30378736 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29455467 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28792692 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28742335 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27932328 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27508333 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27265414 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26917617 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26646850 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26440077 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26362517 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26320780 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25895842 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25636306 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.25485004 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24672896 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23263878 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.22976817 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.22796957 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.21296199 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20600367 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20542805 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.19854580 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18768479 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18696030 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17829412 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.17758333 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.17202510 |
| 115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16417986 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16118750 |
| 117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14442923 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.14042744 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.13851810 |
| 120 | Taste transduction_Homo sapiens_hsa04742 | 0.13371048 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.13330335 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11111082 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.10898290 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09742888 |

